Author

Yunfeng Bai

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

NIR-II-Accelerated 2D-on-2D Silicene/MOF Heterointerfaces Disrupt Tumor Redox Homeostasis for Targeted Ferroptosis

Catalytic ferroptosis therapy provides an attractive approach for tumor treatment, but its practical efficacy is often limited by insufficient reaction kinetics and the strong redox buffering capacity of the tumor microenvironment. Herein, we report an interface-engineered 2D-on-2D catalytic nanoplatform, SNs/FTC@Apt...

Hui Xu, Rong-Jie Zhang, Lu Zhao et al. · Molecular Pharmaceutics · 0 citations

Open access Sep 2026

A ratiometric fluorescence and smartphone-assisted dual-mode sensing platform based on dual-emissive carbon quantum dots for highly sensitive and visual monitoring of ciprofloxacin in food samples.

The abuse of ciprofloxacin (CIP) in animal husbandry poses a threat to public health. In this study, a novel dual-mode sensing platform based on dual-emissive carbon quantum dots (DE-CQDs) combining ratiometric fluorescence and smartphone-assisted visualization was developed for the first time for rapid, ultra-sensitiv...

Li-Zhen Liu, Ya-Ting Zhang, Ting Zhao et al. · Food Chemistry · 0 citations

Jul 2026

Fluorescence-Guided Nanobomb for Triple-Action Tumor Annihilation Based on Fe/Mn Porphyrin MOFs.

Porphyrin bimetallic metal-organic frameworks (BMOFs) have promising applications in photodynamic therapy (PDT) and chemodynamic therapy (CDT) for tumor therapy. However, their therapeutic effect is restricted by the insufficient reactive oxygen species generated by BMOFs. Herein, a nanobomb, Fe-TCPP(Mn)/DOX/PEG/Apt-M...

Aiai Wang, Hui Xu, Zhihui Xin et al. · Molecular Pharmaceutics · 0 citations